搜索
Akero Therapeutics Inc
AKRO添加自选
54.650USD
0.0000.00%
收盘 06/26, 16:00（美东）报价延迟15分钟
4.50B总市值
亏损市盈率 TTM
股东统计
更新时间: 4月29日 周三
更新时间: 4月29日 周三
持股股东
股东类型
持股股东
持股股东
占比
Cheng (Andrew)
0.37%
Rolph (Timothy Peter)
0.29%
Harrison (Seth Loring)
0.17%
Grantham Mayo Van Otterloo & Co LLC
0.14%
Walmsley (Graham G)
0.11%
其他
98.92%
持股股东
持股股东
占比
Cheng (Andrew)
0.37%
Rolph (Timothy Peter)
0.29%
Harrison (Seth Loring)
0.17%
Grantham Mayo Van Otterloo & Co LLC
0.14%
Walmsley (Graham G)
0.11%
其他
98.92%
股东类型
持股股东
占比
Individual Investor
1.08%
Investment Advisor
0.32%
Investment Advisor/Hedge Fund
0.24%
Bank and Trust
0.01%
其他
98.35%
机构持股
更新时间: 4月1日 周三
更新时间: 4月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2026Q1
499
491.95K
0.60%
-100.92M
2025Q4
504
92.63M
123.44%
-26.38K
2025Q3
532
92.72M
128.44%
-619.25K
2025Q2
513
93.19M
122.60%
+5.80M
2025Q1
481
87.41M
107.62%
+1.72M
2024Q4
438
74.28M
124.07%
+570.22K
2024Q3
432
73.67M
126.17%
-695.38K
2024Q2
416
72.42M
128.65%
-3.01M
2024Q1
408
73.91M
107.89%
+1.88M
2023Q4
389
59.72M
117.03%
+1.94M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Cheng (Andrew)
304.10K
0.37%
-89.28K
-22.69%
Nov 20, 2025
Rolph (Timothy Peter)
236.46K
0.29%
+115.58K
+95.62%
Nov 25, 2025
Harrison (Seth Loring)
138.66K
0.17%
-145.70K
-51.24%
Dec 09, 2025
Grantham Mayo Van Otterloo & Co LLC
117.61K
0.14%
-47.45K
-28.75%
Dec 31, 2025
Walmsley (Graham G)
93.00K
0.11%
+90.83K
+4189.67%
Oct 22, 2025
Pictet Asset Management (Japan) Ltd.
64.03K
0.08%
+64.03K
--
Oct 31, 2025
UBS Fund Management (Switzerland) AG
41.23K
0.05%
-1.54K
-3.61%
Jun 30, 2025
Harvest Fund Management Co., Ltd.
40.30K
0.05%
+21.18K
+110.81%
Jun 30, 2025
Yale (Catriona)
35.53K
0.04%
+8.27K
+30.32%
Nov 04, 2025
T. Rowe Price Japan, Inc.
30.90K
0.04%
-3.30K
-9.64%
Apr 30, 2025
查看更多
持股ETF
更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
Simplify Propel Opportunities ETF
11.66%
ProShares Merger ETF
2.71%
State Street SPDR S&P Biotech ETF
1.78%
ALPS Medical Breakthroughs ETF
1.75%
AltShares Merger Arbitrage ETF
1.63%
Direxion Daily S&P Biotech Bull 3X Shares
1.1%
ProShares Ultra Nasdaq Biotechnology
0.43%
Invesco Nasdaq Biotechnology ETF
0.42%
iShares Biotechnology ETF
0.34%
Pacer WealthShield ETF
0.28%
查看更多
Simplify Propel Opportunities ETF
占比11.66%
ProShares Merger ETF
占比2.71%
State Street SPDR S&P Biotech ETF
占比1.78%
ALPS Medical Breakthroughs ETF
占比1.75%
AltShares Merger Arbitrage ETF
占比1.63%
Direxion Daily S&P Biotech Bull 3X Shares
占比1.1%
ProShares Ultra Nasdaq Biotechnology
占比0.43%
Invesco Nasdaq Biotechnology ETF
占比0.42%
iShares Biotechnology ETF
占比0.34%
Pacer WealthShield ETF
占比0.28%
